Patent · US Active

Substituted pyrazolopyrimidinylamino-indazoles

US9556181B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Ulrich Klar · Berlin, DE
Lars Wortmann · Berlin, DE
Georg Kettschau · Berlin, DE
Florian Pühler · Berlin, DE
Philip Lienau · Berlin, DE
Detlev Sülzle · Berlin, DE

Key dates

Filing date	Jan 29, 2014
Grant date	Jan 31, 2017
Priority date	—
Expiry date	Jan 29, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted pyrazolopyrimidinylamino-indazole compounds of formula I, below, as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredientswherein R1a, R1b, R1c, and R2 are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.